Invesco Biotechnology & Genome ETF

PBE

About

PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

Name
Invesco Biotechnology & Genome ETF
Index tracked
Dynamic Biotech&Genome Intellidex TR USD
Type
Equity
Expense ratio
0.59%
Management fee
0.5%
Dividend policy
Quarterly
NAV
USD 101.78 (10/28/2026)
Issued units
4.35M (10/28/2026)
Listing date
Jun 23, 2005
Sponsor
Invesco
Custodian
The Bank of New York Mellon

ETF Documents

Last updatedType
08/27/2026Prospectus
07/06/2026Annual Report